HCA Healthcare stock holds firm after a $20.23 billion quarter
Published on 09/01/2026 at 10:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
HCA Healthcare, Inc. (US40412C1018) held near $417.57 after its most recent quote on August 28, 2026, while the company carried a $90.40 billion market capitalization and a 13.98 P/E ratio. The latest reported quarter, ended June 30, 2026, delivered $20.23 billion in revenue and $7.59 in earnings per share, both stronger than the same period a year earlier.
Quarterly numbers set the tone
The quarter ended June 30, 2026 is the clearest anchor for the shares: revenue rose 8.7% year over year to $20.23 billion, and EPS of $7.59 topped consensus by $0.03. That comparison matters for a stock that was already trading with a market value of $90.40 billion and a valuation multiple of 13.98 times earnings.
The same stock snapshot showed 1.00 million shares traded against average volume of 1.19 million, and the 52-week range of $353.99 to $556.52 framed the August 28 quote in the upper half of the band. The move was modest, but the numbers show the market is still pricing HCA against a strong quarterly base.
Analysts keep it constructive
Analysts currently describe HCA with a Moderate Buy consensus and an average price target of $462.64, while one reported call reduced a target from $635.00 to $579.00 and kept a buy rating. That spread says the debate is less about the business model and more about how much of the recent operating strength is already reflected in the share price.
HCA also reported a quarterly dividend of $0.78 per share, equal to $3.12 annualized and a 0.7% yield. For investors, that adds a second anchor beside earnings: cash returns remain part of the story even as valuation stays tied to the latest quarter.
Hospital network remains the core
HCA Healthcare operates a national network of acute-care hospitals, freestanding surgical and emergency centers, and outpatient clinics. The business mix still runs through inpatient care, surgery, emergency medicine, and outpatient treatment, which makes utilization and reimbursement trends central to the earnings path.
Shares and valuation
HCA Healthcare shares were last quoted at $417.57 on August 28, 2026, with a market cap of $90.40 billion and a 52-week range of $353.99 to $556.52. The stock's latest reported quarter and its current valuation now sit side by side as the main frame for the next move.
More on HCA Healthcare
Company: HCA Healthcare, Inc. | ISIN: US40412C1018 | Ticker: HCA | Exchange: NYSE | Sector / Industry: Health Care / Health Care Providers & Services | Index membership: S&P 500
